0000000000512790

AUTHOR

Uwe Kirschner

showing 2 related works from this author

Quality-of-Life Impairment among Patients with Hidradenitis Suppurativa: A Cross-Sectional Study of 1795 Patients

2021

The chronic, inflammatory skin disorder hidradenitis suppurativa (HS) is associated well documented negative influences on patients&rsquo

medicine.medical_specialtyCross-sectional studyPopulationDiseaseDemographic dataArticleGeneral Biochemistry Genetics and Molecular Biology030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineQuality of lifeInternal medicineMedicineHidradenitis suppurativa030212 general & internal medicineDLQIlcsh:ScienceeducationEcology Evolution Behavior and Systematicseducation.field_of_studyintegumentary systembusiness.industryhidradenitis suppurativaPaleontologyDermatology Life Quality Indexmedicine.diseasehumanitiesquality of lifeSpace and Planetary ScienceCohortlcsh:QbusinessLife
researchProduct

LAight® Therapy Significantly Enhances Treatment Efficacy of 16 Weeks of Topical Clindamycin Solution in Hurley I and II Hidradenitis Suppurativa: Re…

2021

<b><i>Background:</i></b> Hidradenitis suppurativa (HS) is a chronic, inflammatory, burdensome skin disease where medical first-line treatment is still limited to long-term, topical and/or systemic antibiotics. The RELIEVE study aimed at evaluating the efficacy of LAight® therapy – a combination of intense pulsed light and radiofrequency – as an adjunct treatment to first-line therapies in Hurley stage I and II HS. <b><i>Methods:</i></b> The RELIEVE study was performed as a two-period multicenter randomized controlled trial with blinded assessment. For period A from week 0 to week 16, the 88 participating subjects were randomized into either a…

medicine.medical_specialtymedicine.medical_treatmentDermatologyIntense pulsed lightSeverity of Illness Indexlaw.inventionRandomized controlled trialQuality of lifelawInternal medicineClinical endpointMedicineHumansHidradenitis suppurativabusiness.industryClindamycinClindamycinmedicine.diseaseTreatment efficacyAnti-Bacterial AgentsHidradenitis SuppurativaTreatment OutcomeTopical clindamycinChronic DiseaseQuality of Lifebusinessmedicine.drugDermatology (Basel, Switzerland)
researchProduct